Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Clinical trial NCT03942328 · RECRUITING

Trial details

NCT number: NCT03942328
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage III Hepatocellular Carcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Unresectable Hepatocellular Carcinoma Unresectable Intrahepatic Cholangiocarcinoma

Start date: 2019-09-19
Primary completion: 2030-05-31
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.